ValuEngine cut shares of LHC Group (NASDAQ:LHCG) from a buy rating to a hold rating in a research note published on Friday morning.
Several other equities research analysts also recently weighed in on the company. SunTrust Banks restated a buy rating and set a $75.00 price target on shares of LHC Group in a report on Friday, November 3rd. Zacks Investment Research upgraded LHC Group from a hold rating to a buy rating and set a $79.00 price target on the stock in a report on Wednesday, November 8th. Craig Hallum restated a buy rating and set a $80.00 price target (up previously from $67.00) on shares of LHC Group in a report on Tuesday, November 7th. Jefferies Group upped their price target on LHC Group from $68.00 to $83.00 and gave the stock a buy rating in a report on Tuesday, November 7th. They noted that the move was a valuation call. Finally, Robert W. Baird restated a hold rating and set a $63.00 price target on shares of LHC Group in a report on Tuesday, September 12th. Three investment analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. The stock currently has an average rating of Buy and a consensus target price of $77.10.
Shares of LHC Group (NASDAQ LHCG) opened at $64.86 on Friday. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.24. The stock has a market capitalization of $1,196.00, a price-to-earnings ratio of 28.08, a P/E/G ratio of 1.94 and a beta of 0.69. LHC Group has a 1-year low of $41.66 and a 1-year high of $76.14.
In other news, COO Donald Dwayne Stelly sold 2,650 shares of the company’s stock in a transaction dated Friday, September 8th. The stock was sold at an average price of $65.34, for a total transaction of $173,151.00. Following the completion of the transaction, the chief operating officer now directly owns 109,235 shares of the company’s stock, valued at approximately $7,137,414.90. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 14.80% of the company’s stock.
Several large investors have recently added to or reduced their stakes in LHCG. Nine Chapters Capital Management LLC acquired a new stake in shares of LHC Group in the 3rd quarter valued at about $255,000. Bessemer Group Inc. boosted its position in shares of LHC Group by 17.2% in the 3rd quarter. Bessemer Group Inc. now owns 20,400 shares of the health services provider’s stock valued at $1,447,000 after purchasing an additional 3,000 shares during the period. Smith Asset Management Group LP acquired a new stake in shares of LHC Group in the 3rd quarter valued at about $1,421,000. Great West Life Assurance Co. Can boosted its position in shares of LHC Group by 3.7% in the 2nd quarter. Great West Life Assurance Co. Can now owns 22,229 shares of the health services provider’s stock valued at $1,508,000 after purchasing an additional 790 shares during the period. Finally, Linscomb & Williams Inc. acquired a new stake in shares of LHC Group in the 2nd quarter valued at about $2,268,000. 85.51% of the stock is owned by institutional investors and hedge funds.
LHC Group Company Profile
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.
To view ValuEngine’s full report, visit ValuEngine’s official website.
What are top analysts saying about LHC Group? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for LHC Group and related companies.